ilomastat has been researched along with oleic acid in 2 studies
| Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (oleic acid) | Trials (oleic acid) | Recent Studies (post-2010) (oleic acid) |
|---|---|---|---|---|---|
| 103 | 0 | 45 | 8,768 | 248 | 3,051 |
| Protein | Taxonomy | ilomastat (IC50) | oleic acid (IC50) |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, CF; Feng, NH; Lin, HI; Wang, D; Wang, NT; Yeh, DY | 1 |
2 other study(ies) available for ilomastat and oleic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Matrix metalloprotease expressions in both reperfusion lung injury and oleic acid lung injury models and the protective effects of ilomastat.
Topics: Animals; Enzyme Inhibitors; Femoral Vein; Hydroxamic Acids; Hydroxyl Radical; Indoles; Leukocyte Count; Lung; Lung Injury; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Oleic Acid; Organ Size; Polymerase Chain Reaction; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; RNA, Messenger | 2009 |